A research study titled, “Diabetic Retinopathy Market by Type, Treatment, and End User - Global
Industry Analysis and Forecast to 2025” published by Crystal Market Research,
states that the diabetic retinopathy market is projected to be around $2.6
billion by 2025.
Diabetic
retinopathy (DR) is a condition that occurs in individuals suffering from
diabetes. It is a severe sight-threatening problem of diabetes which
progressively damages the light-sensitive lining at the back of the eye i.e.
retina. This condition occurs when blood vessels leak blood. Therefore, the
retinal tissue swells leading to blurred vision. If DR is not treated on time,
it can cause blindness. According to a study conducted by American Diabetes
Association, 415 million people worldwide suffered from diabetes and diabetes
related complications as of 2015, and this number is expected to reach 642
million by 2040. Prevalence of diabetes retinopathy is higher in people
suffering from type-1 diabetes for prolonged period. Such high incidence of
diabetic retinopathy can be attributed to rise in chronic conditions such as
hyperglycemia, rise in obesity rate, rise in hypertension, and genetic factors
of individuals.
Browse full
research report with TOC on “Diabetic Retinopathy Market by Type, Treatment,
and End User - Global Industry Analysis and Forecast to 2025” at: http://www.crystalmarketresearch.com/report/diabetic-retinopathy-market
Diabetic
macular edema market is expected to witness high growth during forecast period.
This can be attributed to number of factors such as rise in prevalence of
diabetic retinopathy, growing aging population and the changing lifestyle.
Anti-VEGF treatment segment accounted for the largest share due to more usage
of these medicines for quicker recovery of patients. However, laser surgery
segment is expected to witness high growth rate during the forecast period.
North
America dominated the global diabetic retinopathy market in 2016. This can be
attributed to number of factors such as increasing prevalence of diabetes, high
adoption of advanced products, and favorable reimbursement policies.
Asia-Pacific is expected to witness high growth rate, due to high patient
population, increasing healthcare spending, and increased focus of international
players on emerging markets owing to growing preference for advanced healthcare
facilities and rising disposable income of people.
Diabetic
retinopathy market is highly competitive in nature with the presence of large
number of players such as Bayer AG, F. Hoffmann-La Roche, Allergan plc, Alimera
Sciences, Novartis International AG, Pfizer, Regeneron Pharmaceuticals Inc.,
Ampio Pharmaceuticals., Abbott Laboratories, and Valeant Pharmaceutical.
Request a sample
copy of Diabetic Retinopathy Market Research Report @ http://www.crystalmarketresearch.com/report-sample/HC0622
Key Findings of the Research
Study:
·
Laser
surgery segment occupied more than two-fifth of the global market in 2016, due
to high adoption of this technique for the treatment of diabetic retinopathy.
·
Proliferative
retinopathy occupied largest share of the global diabetic retinopathy market in
2016, due to rising geriatric population rapidly moving towards proliferative
stage of retinopathy.
·
U.S.
dominated the NorthAmerica market in 2016, due to high market penetration of
drugs such as Avastinand Eylea.
·
Europe
occupied the second largest share of the global market in 2016. This can be
attributed to rise in diabetic population, high adoption of technologically
advanced products, and rise in demand for early screening techniques.
·
Asia-Pacific
is expected to witness high growth rate during the
forecast period due to large diabetic population base and increasing awareness
about diabetes and availability of treatment options.
Inquire more about
this report at: http://www.crystalmarketresearch.com/send-an-enquiry/HC0622
Diabetic
Retinopathy Market is
segmented as follows –
By
Type:
- Proliferative Diabetic Retinopathy
- Diabetic Macular Edema
By
Management:
- Anti VEGF Drugs
- Steroid Implants
- Laser Surgeries
- Vitrectomy
By Region:
- North America
o U.S
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
- Rest of the World
o Brazil
o South Africa
o Saudi Arabia
o Turkey
o United Arab Emirates
o Others
Get Customization
in the Report At: http://www.crystalmarketresearch.com/customization/HC0622
Related Reports:
Diabetic Macular
Edema Market by Indication Type, Treatment Type End Users - Global Industry
Analysis and Forecast to 2025: http://www.crystalmarketresearch.com/report/diabetic-macular-edema-market
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact:
Akhil
V.
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll
Free: +1-888-213-4282
Website: http://www.crystalmarketresearch.com
No comments:
Post a Comment